Novel approaches for determination of antiretroviral reverse transcriptase inhibitor agent in commercial dosage forms by using spectrofluorimetric, first derivative spectrophotometric, and HPLC methods

[1] Zhou HY(2012)Mass analysis of tenofovir disoproxil fumarate and determination of fumarate combination ratio by NMR Chinese Journal of Pharmaceutical Analysis 32 2180-2183

[2] Chen XH(2015)Rapid stability indicating RP-HPLC method for simultaneous quantification of related impurities of antiretroviral drugs Asian J Chem 27 2393-2395

[3] Li W(2015)Determination of the related substances of tenofovir by RP-HPLC Journal of China Pharmaceutical University 46 78-80

[4] Guan SY(2015)Development of a validated HPLC method for the determination of tenofovir disoproxil fumarate using a green enrichment process Anal Methods 7 6290-6298

[5] Kalpana J(2015)Selective RP-HPLC DAD method for determination of tenofovir fumarate and emtricitabine in bulk powder and in tablets Acta Chromatogr 27 41-54

[6] Himaja M(2014)Method development and validation for simultaneous estimation of lamivudine, tenofovir and efavirenz in combined tablet dosage form by RP-HPLC and UV-spectroscopic method Int J Pharm Sci Res 5 5491-5497

[7] Anbarasu C(2003)Determination of Tenofovir in human plasma by high-performance liquid chromatography with spectrofluorimetric detection J Chromatogr B Anal Technol Biomed Life Sci 785 377-381

[8] Liu C(2009)Simultaneous quantification of a non-nucleoside reverse transcriptase inhibitor efavirenz, a nucleoside reverse transcriptase inhibitor emtricitabine and a nucleotide reverse transcriptase inhibitor tenofovir in plasma by liquid chromatography positive ion electrospray tandem mass spectrometry Biomed Chromatogr 23 371-381

[9] Zhong X(2014)Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with HPLC-MS/MS J Pharm Biomed Anal 88 144-151

[10] Xi Y(2013)Pharmacokinetics of tenofovir in Beagle dogs after oral dosing of tenofovir disoproxil fumarate using HPLC-MS/MS analysis Yaoxue Xuebao 48 390-394

[1] Zhou HY(2012)Mass analysis of tenofovir disoproxil fumarate and determination of fumarate combination ratio by NMR Chinese Journal of Pharmaceutical Analysis 32 2180-2183

[2] Chen XH(2015)Rapid stability indicating RP-HPLC method for simultaneous quantification of related impurities of antiretroviral drugs Asian J Chem 27 2393-2395

[3] Li W(2015)Determination of the related substances of tenofovir by RP-HPLC Journal of China Pharmaceutical University 46 78-80

[4] Guan SY(2015)Development of a validated HPLC method for the determination of tenofovir disoproxil fumarate using a green enrichment process Anal Methods 7 6290-6298

[5] Kalpana J(2015)Selective RP-HPLC DAD method for determination of tenofovir fumarate and emtricitabine in bulk powder and in tablets Acta Chromatogr 27 41-54

[6] Himaja M(2014)Method development and validation for simultaneous estimation of lamivudine, tenofovir and efavirenz in combined tablet dosage form by RP-HPLC and UV-spectroscopic method Int J Pharm Sci Res 5 5491-5497

[7] Anbarasu C(2003)Determination of Tenofovir in human plasma by high-performance liquid chromatography with spectrofluorimetric detection J Chromatogr B Anal Technol Biomed Life Sci 785 377-381

[8] Liu C(2009)Simultaneous quantification of a non-nucleoside reverse transcriptase inhibitor efavirenz, a nucleoside reverse transcriptase inhibitor emtricitabine and a nucleotide reverse transcriptase inhibitor tenofovir in plasma by liquid chromatography positive ion electrospray tandem mass spectrometry Biomed Chromatogr 23 371-381

[9] Zhong X(2014)Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with HPLC-MS/MS J Pharm Biomed Anal 88 144-151

[10] Xi Y(2013)Pharmacokinetics of tenofovir in Beagle dogs after oral dosing of tenofovir disoproxil fumarate using HPLC-MS/MS analysis Yaoxue Xuebao 48 390-394